SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RT who wrote (13463)8/17/1998 10:30:00 AM
From: VLAD  Read Replies (1) of 23519
 
RT,

I believe that the meetings with institutional investors last week has resulted in institutional accumulation of Vivus stock. Vivus was probably giving the institutions a lot of the positive information regarding MUSE earnings potential in foreign markets. It is a big mistake to think that sales of MUSE in the US in the presence of Viagra will correlate to sales in other countries. Don't forget that millions of Viagra tablets have already been sold on black markets so in essence for those who really wanted it, Viagra already has a significant head start on MUSE. Again, we must keep a close eye on what happens with MUSE sales in countries such as Switzerland and England. Don't forget about the big A card Vivus still holds.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News